Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Biohaven completes patient enrolment in rimegepant trial for migraine

The primary outcome measure of the trial is the change from baseline at week 12 in the mean number of migraine days per month. Credit: jypsygen.